BACKGROUND: Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by recurrent infections and defective immunoglobulin production. METHODS: The DEFI French national prospective study investigated peripheral T-cell and B-cell compartments in 313 CVID patients grouped according to their clinical phenotype, using flow cytometry. RESULTS: In patients developing infection only (IO), the main B-cell or T-cell abnormalities were a defect in switched memory B cells and a decrease in naive CD4(+) T cells associated with an increase in CD4(+)CD95(+) cells. These abnormalities were more pronounced in patients developing lymphoproliferation (LP), autoimmune cytopenia (AC), or chronic enteropathy (CE). Moreover, LP and AC patients presented an increase in CD21(low) B cells and CD4(+)HLA-DR(+) T cells and a decrease in regulatory T cells. CONCLUSION: In these large series of CVID patients, the major abnormalities of the B-cell and T-cell compartments, although a hallmark of CVID, were only observed in half of the IO patients and were more frequent and severe in patients with additional lymphoproliferative, autoimmune, and digestive complications.
BACKGROUND: Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by recurrent infections and defective immunoglobulin production. METHODS: The DEFI French national prospective study investigated peripheral T-cell and B-cell compartments in 313 CVIDpatients grouped according to their clinical phenotype, using flow cytometry. RESULTS: In patients developing infection only (IO), the main B-cell or T-cell abnormalities were a defect in switched memory B cells and a decrease in naive CD4(+) T cells associated with an increase in CD4(+)CD95(+) cells. These abnormalities were more pronounced in patients developing lymphoproliferation (LP), autoimmune cytopenia (AC), or chronic enteropathy (CE). Moreover, LP and AC patients presented an increase in CD21(low) B cells and CD4(+)HLA-DR(+) T cells and a decrease in regulatory T cells. CONCLUSION: In these large series of CVIDpatients, the major abnormalities of the B-cell and T-cell compartments, although a hallmark of CVID, were only observed in half of the IO patients and were more frequent and severe in patients with additional lymphoproliferative, autoimmune, and digestive complications.
Authors: Antonello Giovannetti; Marina Pierdominici; Francesca Mazzetta; Marco Marziali; Cristina Renzi; Anna Maria Mileo; Marco De Felice; Barbara Mora; Antonella Esposito; Rossella Carello; Antonio Pizzuti; Marco G Paggi; Roberto Paganelli; Walter Malorni; Fernando Aiuti Journal: J Immunol Date: 2007-03-15 Impact factor: 5.422
Authors: S Fournier; C Rabian; C Alberti; M V Carmagnat; J F Garin; D Charron; F Derouin; J M Molina Journal: J Infect Dis Date: 2001-05-01 Impact factor: 5.226
Authors: M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs Journal: Proc Natl Acad Sci U S A Date: 1994-02-01 Impact factor: 11.205
Authors: B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler Journal: J Clin Immunol Date: 2003-09 Impact factor: 8.317
Authors: L J Maarschalk-Ellerbroek; P A de Jong; J M van Montfrans; J W J Lammers; A C Bloem; A I M Hoepelman; P M Ellerbroek Journal: J Clin Immunol Date: 2014-06-21 Impact factor: 8.317
Authors: Nicole M Chase; James W Verbsky; Mary K Hintermeyer; Jill K Waukau; Aoy Tomita-Mitchell; James T Casper; Sumit Singh; Kaushik S Shahir; William B Tisol; Melodee L Nugent; R Nagarjun Rao; A Craig Mackinnon; Lawrence R Goodman; Pippa M Simpson; John M Routes Journal: J Clin Immunol Date: 2012-08-29 Impact factor: 8.317
Authors: E A L Bateman; L Ayers; R Sadler; M Lucas; C Roberts; A Woods; K Packwood; J Burden; D Harrison; N Kaenzig; M Lee; H M Chapel; B L Ferry Journal: Clin Exp Immunol Date: 2012-11 Impact factor: 4.330
Authors: Silje F Jørgensen; Henrik M Reims; Didrik Frydenlund; Kristian Holm; Vemund Paulsen; Annika E Michelsen; Kristin K Jørgensen; Liv T Osnes; Jorunn Bratlie; Tor J Eide; Christen P Dahl; Ellen Holter; Rune R Tronstad; Kurt Hanevik; Hans-Richard Brattbakk; Fatemeh Kaveh; Torunn Fiskerstrand; Anne-Marte B Kran; Thor Ueland; Tom H Karlsen; Pål Aukrust; Knut E A Lundin; Børre Fevang Journal: Am J Gastroenterol Date: 2016-08-16 Impact factor: 10.864
Authors: G K Wong; S Goldacker; C Winterhalter; B Grimbacher; H Chapel; M Lucas; D Alecsandru; D McEwen; I Quinti; H Martini; C Milito; R E Schmidt; D Ernst; T Espanol; A Vidaller; J Carbone; E Fernandez-Cruz; V Lougaris; A Plebani; N Kutukculer; L I Gonzalez-Granado; R Contreras; S Kiani-Alikhan; M A A Ibrahim; J Litzman; A Jones; H B Gaspar; L Hammarstrom; U Baumann; K Warnatz; A P Huissoon Journal: Clin Exp Immunol Date: 2013-04 Impact factor: 4.330